We provide you with Advanced Materials that will take your products to the next level. With our silk-based fully functional biopolymers, we enable your products to create USPs for your customers.
Environmentally friendly process
No plastics are involved
Jens Klein Managing Director/CEO
Before joining AMSilk in 2014, Mr. Klein worked for Evonik Industries AG. In 2011, Evonik acquired nanoresins AG and Hanse Chemie AG. Mr Klein served as a member of the Managing Board of both companies since 2006. Prior, Mr. Klein was a member of the Managing Board of the holding company Mulligan BioCapital AG where he played a key role in two initial public offerings of portfolio companies at NASDAQ, one initial public offering at Prime Standard in Frankfurt as well as trade sales to strategic investors. Before joining Mulligan, he was with Fresenius AG, Bad Homburg, where he headed subsidiaries as CEO or CFO. Mr. Klein is a graduate of the University of Mannheim and has an MBA of the Zicklin School of Business, City University of New York.
Dr. Lin Römer Managing Director/CSO
Dr. Römer has more than 10 years of expertise in the field of silk technology. He is co-inventor of several patent applications in this area and has been the key to transferring academic achievements into marketable products.
He is a professional in Chemistry and Biochemistry and received his doctorate from the Technische Universität München. As cofounder of AMSilk he joined the company in 2008. He is responsible for all research and development activities of AMSilk. Since 2013 he holds the position of Managing Director of AMSilk.
“Spidersilk is one of the most stable, naturally occurring substance and could be used for applications such as automotive safety equipment or protective gear.”
“In nature we find perfect materials, how-ever copying them is often difficult. If it is successful, we could change the world – in the same way as bronze did thousands of years ago.”
“Spidersilk has amazing qualities – and is well-tolerated by the human body. For this reason, it is planned to use it in medicine: nerves and wound healing is just the beginning.”
“Spidersilk is an absolutely fascinating material, which is unparalleled in the world.”
BR Bayerischer Rundfunk
Dr. Wolfgang Colberg
Industrial Partner, CVC Capital Partners
CFO of Evonik AG. Before he served as CFO for BSH and in various senior management positions within Bosch
Dr. Matthias Kromayer
Member of the Board at MIG Fonds
Served more than 10 years as management consultant and is a Member of the Supervisory Board of several high-tech companies
CEO Schoeller Textil AG
Various senior management positions at Ciba Geigy (now Novartis) and BASF
Through AT Newtec GmbH the Hexal Founders Dres. Andreas and Thomas Strüngmann are the majority shareholders of AMSilk GmbH. AT Newtec GmbH invests in young non-listed companies.
MIG Fonds invests in young non-listed companies in the German-speaking region concentrating their investment on pharma, biotech, cleantech, new materials & information technology. MIG Fonds offer private investors the change to participate directly in a portfolio of promising technology companies.
Technische Universität München (TUM) is one of Europe’s top universities. The university forges strong links with companies and scientific institutions across the world. TUM was one of the first universities in Germany to be named a University of Excellence. Moreover, TUM regularly ranks among the best European universities in international rankings.
Get in touch
Learn more about new products and applications. Leave your email here and we’ll get in touch.